Prognostic biomarker candidates of neoadjuvant chemotherapy for luminal B-positive locally advanced breast cancer.

被引：0
|
作者：
Liu, Zhaoyun
Wang, Jinjin
Yuan, Chenxi
Yu, Zhiyong
Wu, Wendy
Wu, Lin
Yu, Jinming
机构：
[1] Shandong Univ, Shandong Canc Hosp, Jinan, Peoples R China
[2] Berry Oncol CO LTD, Beijing, Peoples R China
[3] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12638
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dose-intensive chemotherapy for locally advanced breast cancer.
    Schrama J.G.
    Rodenhuis S.
    Current Oncology Reports, 1999, 1 (1) : 23 - 30
  • [42] Neoadjuvant cisplatin and doxorubicin in locally advanced triple negative breast cancer.
    Mateen, Abdul
    Adil, Allah Rakha
    Maken, Rab Nawaz
    Hashmi, Quratul Ain
    Abdullah, Famya
    Duraishi, Arif Moin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [43] The Prognostic Impact of Body Composition for Locally Advanced Breast Cancer Patients Who Received Neoadjuvant Chemotherapy
    Iwase, Toshiaki
    Parikh, Aaroh
    Dibaj, Seyedeh S.
    Shen, Yu
    Shrimanker, Tushaar Vishal
    Chainitikun, Sudpreeda
    Kida, Kumiko
    Sapon, Maryanne E.
    Sahin, Onur
    James, Anjali
    Medrano, Andrea Yizel Delgado
    Klopp, Ann H.
    Ueno, Naoto T.
    CANCERS, 2021, 13 (04) : 1 - 11
  • [44] Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective
    Marc Schegerin
    Anna N. A. Tosteson
    Peter A. Kaufman
    Keith D. Paulsen
    Brian W. Pogue
    Breast Cancer Research and Treatment, 2009, 114
  • [45] TOX3 as a novel biomarker in luminal B breast cancer.
    Hong, Jenny Jimmy
    Seksenyan, Akop
    Yuan, Xiaopu
    Knudsen, Beatrice
    Audeh, William
    Kaye, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [46] Locally advanced breast cancer.
    Sikov W.M.
    Current Treatment Options in Oncology, 2000, 1 (3) : 228 - 238
  • [47] Prognostic Significance of Biomarker Discordance in Breast Cancer Patients with Neoadjuvant Chemotherapy
    Matsumoto, Akiko
    Yoshikawa, Mio
    Takahashi, Yoko
    Jinno, Hiromitsu
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Prognostic imaging in neoadjuvant chemotherapy of locally-advanced breast cancer should be cost-effective
    Schegerin, Marc
    Tosteson, Anna N. A.
    Kaufman, Peter A.
    Paulsen, Keith D.
    Pogue, Brian W.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 537 - 547
  • [49] Prognostic significance of biomarker discordance in breast cancer patients with neoadjuvant chemotherapy
    Matsumoto, A.
    Yoshikawa, M.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2017, 28 : 19 - 19
  • [50] Prognostic significance of biomarker discordance after neoadjuvant chemotherapy in breast cancer
    Matsumoto, A.
    Jinno, H.
    Ando, T.
    Fujii, T.
    Nakamura, T.
    Saito, J.
    Takahashi, M.
    Hayashida, T.
    Kitagawa, Y.
    BREAST, 2015, 24 : S96 - S97
12345